Cargando…

1598P Acceptance of SARS-CoV-2 vaccination among patients with cancer undergoing immunosuppressive therapy: Portuguese study

Detalles Bibliográficos
Autores principales: de Sousa, M.J.P., Caramujo, C., Julio, N., Magalhães, J. Correia, Basto, R., Fraga, T., Gomes, I. Ferreira, Pazos, I., Sousa, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454393/
http://dx.doi.org/10.1016/j.annonc.2021.08.1591
_version_ 1784570483616776192
author de Sousa, M.J.P.
Caramujo, C.
Julio, N.
Magalhães, J. Correia
Basto, R.
Fraga, T.
Gomes, I. Ferreira
Pazos, I.
Sousa, G.
author_facet de Sousa, M.J.P.
Caramujo, C.
Julio, N.
Magalhães, J. Correia
Basto, R.
Fraga, T.
Gomes, I. Ferreira
Pazos, I.
Sousa, G.
author_sort de Sousa, M.J.P.
collection PubMed
description
format Online
Article
Text
id pubmed-8454393
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Society for Medical Oncology. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-84543932021-09-21 1598P Acceptance of SARS-CoV-2 vaccination among patients with cancer undergoing immunosuppressive therapy: Portuguese study de Sousa, M.J.P. Caramujo, C. Julio, N. Magalhães, J. Correia Basto, R. Fraga, T. Gomes, I. Ferreira Pazos, I. Sousa, G. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2021-09 2021-09-21 /pmc/articles/PMC8454393/ http://dx.doi.org/10.1016/j.annonc.2021.08.1591 Text en Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
de Sousa, M.J.P.
Caramujo, C.
Julio, N.
Magalhães, J. Correia
Basto, R.
Fraga, T.
Gomes, I. Ferreira
Pazos, I.
Sousa, G.
1598P Acceptance of SARS-CoV-2 vaccination among patients with cancer undergoing immunosuppressive therapy: Portuguese study
title 1598P Acceptance of SARS-CoV-2 vaccination among patients with cancer undergoing immunosuppressive therapy: Portuguese study
title_full 1598P Acceptance of SARS-CoV-2 vaccination among patients with cancer undergoing immunosuppressive therapy: Portuguese study
title_fullStr 1598P Acceptance of SARS-CoV-2 vaccination among patients with cancer undergoing immunosuppressive therapy: Portuguese study
title_full_unstemmed 1598P Acceptance of SARS-CoV-2 vaccination among patients with cancer undergoing immunosuppressive therapy: Portuguese study
title_short 1598P Acceptance of SARS-CoV-2 vaccination among patients with cancer undergoing immunosuppressive therapy: Portuguese study
title_sort 1598p acceptance of sars-cov-2 vaccination among patients with cancer undergoing immunosuppressive therapy: portuguese study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454393/
http://dx.doi.org/10.1016/j.annonc.2021.08.1591
work_keys_str_mv AT desousamjp 1598pacceptanceofsarscov2vaccinationamongpatientswithcancerundergoingimmunosuppressivetherapyportuguesestudy
AT caramujoc 1598pacceptanceofsarscov2vaccinationamongpatientswithcancerundergoingimmunosuppressivetherapyportuguesestudy
AT julion 1598pacceptanceofsarscov2vaccinationamongpatientswithcancerundergoingimmunosuppressivetherapyportuguesestudy
AT magalhaesjcorreia 1598pacceptanceofsarscov2vaccinationamongpatientswithcancerundergoingimmunosuppressivetherapyportuguesestudy
AT bastor 1598pacceptanceofsarscov2vaccinationamongpatientswithcancerundergoingimmunosuppressivetherapyportuguesestudy
AT fragat 1598pacceptanceofsarscov2vaccinationamongpatientswithcancerundergoingimmunosuppressivetherapyportuguesestudy
AT gomesiferreira 1598pacceptanceofsarscov2vaccinationamongpatientswithcancerundergoingimmunosuppressivetherapyportuguesestudy
AT pazosi 1598pacceptanceofsarscov2vaccinationamongpatientswithcancerundergoingimmunosuppressivetherapyportuguesestudy
AT sousag 1598pacceptanceofsarscov2vaccinationamongpatientswithcancerundergoingimmunosuppressivetherapyportuguesestudy